Literature DB >> 22647630

Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.

Kate Witkowska1, Kyla M Smith, Sylvia Y M Yao, Amy M L Ng, Debbie O'Neill, Edward Karpinski, James D Young, Christopher I Cheeseman.   

Abstract

Human SLC2A9 (GLUT9) is a novel high-capacity urate transporter belonging to the facilitated glucose transporter family. In the present study, heterologous expression in Xenopus oocytes has allowed us to undertake an in-depth radiotracer flux and electrophysiological study of urate transport mediated by both isoforms of SLC2A9 (a and b). Addition of urate to SLC2A9-producing oocytes generated outward currents, indicating electrogenic transport. Urate transport by SLC2A9 was voltage dependent and independent of the Na(+) transmembrane gradient. Urate-induced outward currents were affected by the extracellular concentration of Cl(-), but there was no evidence for exchange of the two anions. [(14)C]urate flux studies under non-voltage-clamped conditions demonstrated symmetry of influx and efflux, suggesting that SLC2A9 functions in urate efflux driven primarily by the electrochemical gradient of the cell. Urate uptake in the presence of intracellular hexoses showed marked differences between the two isoforms, suggesting functional differences between the two splice variants. Finally, the permeant selectivity of SLC2A9 was examined by testing the ability to transport a panel of radiolabeled purine and pyrimidine nucleobases. SLC2A9 mediated the uptake of adenine in addition to urate, but did not function as a generalized nucleobase transporter. The differential expression pattern of the two isoforms of SLC2A9 in the human kidney's proximal convoluted tubule and its electrogenic transport of urate suggest that these transporters play key roles in the regulation of plasma urate levels and are therefore potentially important participants in hyperuricemia and hypouricemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647630      PMCID: PMC3423118          DOI: 10.1152/ajprenal.00134.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  42 in total

1.  Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.

Authors:  Wolfgang Rathmann; Burkhard Haastert; Andrea Icks; Guido Giani; Jeffrey M Roseman
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 8.082

Review 2.  New insights into renal transport of urate.

Authors:  Naohiko Anzai; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Curr Opin Rheumatol       Date:  2007-03       Impact factor: 5.006

3.  Urate transport across the apical membrane of renal proximal tubules.

Authors:  Hitoshi Endou; Naohiko Anzai
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-06       Impact factor: 1.381

4.  Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs.

Authors:  Xue-Qing Yu; Charlie Changli Xue; Guangji Wang; Shu-Feng Zhou
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

Review 5.  Dietary fructose and the metabolic syndrome.

Authors:  Abigale Miller; Khosrow Adeli
Journal:  Curr Opin Gastroenterol       Date:  2008-03       Impact factor: 3.287

6.  Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.

Authors:  Jesper Hjortnaes; Ale Algra; Jobien Olijhoek; Margriet Huisman; Johannes Jacobs; Yolanda van der Graaf; Frank Visseren
Journal:  J Rheumatol       Date:  2007-08-01       Impact factor: 4.666

7.  SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.

Authors:  Veronique Vitart; Igor Rudan; Caroline Hayward; Nicola K Gray; James Floyd; Colin N A Palmer; Sara A Knott; Ivana Kolcic; Ozren Polasek; Juergen Graessler; James F Wilson; Anthony Marinaki; Philip L Riches; Xinhua Shu; Branka Janicijevic; Nina Smolej-Narancic; Barbara Gorgoni; Joanne Morgan; Susan Campbell; Zrinka Biloglav; Lovorka Barac-Lauc; Marijana Pericic; Irena Martinovic Klaric; Lina Zgaga; Tatjana Skaric-Juric; Sarah H Wild; William A Richardson; Peter Hohenstein; Charley H Kimber; Albert Tenesa; Louise A Donnelly; Lynette D Fairbanks; Martin Aringer; Paul M McKeigue; Stuart H Ralston; Andrew D Morris; Pavao Rudan; Nicholas D Hastie; Harry Campbell; Alan F Wright
Journal:  Nat Genet       Date:  2008-03-09       Impact factor: 38.330

8.  SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.

Authors:  Angela Döring; Christian Gieger; Divya Mehta; Henning Gohlke; Holger Prokisch; Stefan Coassin; Guido Fischer; Kathleen Henke; Norman Klopp; Florian Kronenberg; Bernhard Paulweber; Arne Pfeufer; Dieter Rosskopf; Henry Völzke; Thomas Illig; Thomas Meitinger; H-Erich Wichmann; Christa Meisinger
Journal:  Nat Genet       Date:  2008-03-09       Impact factor: 38.330

9.  Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.

Authors:  Chris Wallace; Stephen J Newhouse; Peter Braund; Feng Zhang; Martin Tobin; Mario Falchi; Kourosh Ahmadi; Richard J Dobson; Ana Carolina B Marçano; Cother Hajat; Paul Burton; Panagiotis Deloukas; Morris Brown; John M Connell; Anna Dominiczak; G Mark Lathrop; John Webster; Martin Farrall; Tim Spector; Nilesh J Samani; Mark J Caulfield; Patricia B Munroe
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

10.  Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.

Authors:  Klaus Stark; Wibke Reinhard; Katharina Neureuther; Silke Wiedmann; Kamil Sedlacek; Andrea Baessler; Marcus Fischer; Stefan Weber; Bernhard Kaess; Jeanette Erdmann; Heribert Schunkert; Christian Hengstenberg
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

View more
  22 in total

Review 1.  The facilitative glucose transporter GLUT12: what do we know and what would we like to know?

Authors:  Jonai Pujol-Giménez; Jaione Barrenetxe; Pedro González-Muniesa; Maria Pilar Lostao
Journal:  J Physiol Biochem       Date:  2012-10-03       Impact factor: 4.158

2.  Genetic risk scores, sex and dietary factors interact to alter serum uric acid trajectory among African-American urban adults.

Authors:  May A Beydoun; Jose-Atilio Canas; Marie T Fanelli-Kuczmarski; Salman M Tajuddin; Michele K Evans; Alan B Zonderman
Journal:  Br J Nutr       Date:  2017-03-27       Impact factor: 3.718

3.  Critical Roles of Two Hydrophobic Residues within Human Glucose Transporter 9 (hSLC2A9) in Substrate Selectivity and Urate Transport.

Authors:  Wentong Long; Pankaj Panwar; Kate Witkowska; Kenneth Wong; Debbie O'Neill; Xing-Zhen Chen; M Joanne Lemieux; Chris I Cheeseman
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

4.  Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.

Authors:  C C Wen; S W Yee; X Liang; T J Hoffmann; M N Kvale; Y Banda; E Jorgenson; C Schaefer; N Risch; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2015-04-06       Impact factor: 6.875

5.  Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients.

Authors:  Fernando Perez-Ruiz; Maria Angeles Aniel-Quiroga; Ana María Herrero-Beites; Sandra Pamela Chinchilla; Gorka Garcia Erauskin; Toni Merriman
Journal:  Rheumatol Int       Date:  2015-03-13       Impact factor: 2.631

6.  Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels.

Authors:  Humaira Rasheed; Kim Hughes; Tanya J Flynn; Tony R Merriman
Journal:  Circ Cardiovasc Genet       Date:  2014-09-23

7.  The apical sorting signal for human GLUT9b resides in the N-terminus.

Authors:  Kristin P Bibee; Robert Augustin; Vered Gazit; Kelle H Moley
Journal:  Mol Cell Biochem       Date:  2013-01-30       Impact factor: 3.396

8.  Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.

Authors:  Andrea Mancikova; Vladimir Krylov; Olha Hurba; Ivan Sebesta; Makiko Nakamura; Kimiyoshi Ichida; Blanka Stiburkova
Journal:  Clin Exp Nephrol       Date:  2015-10-24       Impact factor: 2.801

Review 9.  Human placental glucose transport in fetoplacental growth and metabolism.

Authors:  Nicholas P Illsley; Marc U Baumann
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-12-26       Impact factor: 5.187

10.  Fucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells.

Authors:  Yu Zhang; Xiaohui Tan; Zhen Lin; Fangping Li; Chunyan Yang; Haiying Zheng; Lingyu Li; Huazhong Liu; Jianghua Shang
Journal:  Mar Drugs       Date:  2021-04-23       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.